Cancer Research Aziza Shad  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, M.
Right arrow Articles by Xiao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, M.
Right arrow Articles by Xiao, H.
[Cancer Research 63, 8763-8767, December 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

TIP30 Deficiency Increases Susceptibility to Tumorigenesis

Mitsuhiro Ito1, Chao Jiang2, Kristy Krumm2, Xia Zhang4, Jill Pecha23, Jian Zhao4, Yajun Guo24, Robert G. Roeder1 and Hua Xiao23

1 Laboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, New York;
2 Eppley Institute for Cancer Research, and
3 Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska; and
4 International Joint Cancer Institute and Eastern Hospital of Hepatobiliary Surgery, Shanghai, People’s Republic of China

TIP30, also called CC3 or Htatip2, is a putative metastasis suppressor that promotes apoptosis and inhibits angiogenesis. Although TIP30 has several characteristic features of a tumor suppressor in in vitro analyses, tumor development as a result of TIP30 inactivation has not been demonstrated in vivo, and abnormal expression of TIP30 in human cancer has not been reported. Using genetically engineered mice and cells deficient in TIP30, we show that TIP30-deficient mice have a high incidence of hepatocellular carcinoma and other tumors, and loss of TIP30 enhances susceptibility of fibroblasts to transformation by the SV40 large T antigen. Furthermore, immunohistochemical analysis indicates that reduced TIP30 expression is associated with 33% of human hepatocellular carcinomas. Some of these carcinomas harbor missense mutations in the Tip30 gene, which cause abnormal expression of TIP30. Together, these results demonstrate that the Tip30 gene is a tumor susceptibility gene playing an important role in the suppression of hepatocarcinogenesis.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
X. Tong, K. Li, Z. Luo, B. Lu, X. Liu, T. Wang, M. Pang, B. Liang, M. Tan, M. Wu, et al.
Decreased TIP30 Expression Promotes Tumor Metastasis in Lung Cancer
Am. J. Pathol., May 1, 2009; 174(5): 1931 - 1939.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Lu, Y. Ma, G. Wu, X. Tong, H. Guo, A. Liang, W. Cong, C. Liu, H. Wang, M. Wu, et al.
Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
Clin. Cancer Res., November 15, 2008; 14(22): 7405 - 7412.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhao, J. Chen, B. Lu, L. Dong, H. Wang, C. Bi, G. Wu, H. Guo, M. Wu, and Y. Guo
TIP30 Induces Apoptosis under Oxidative Stress through Stabilization of p53 Messenger RNA in Human Hepatocellular Carcinoma
Cancer Res., June 1, 2008; 68(11): 4133 - 4141.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Hanke, I. Kausch, G. Dahmen, D. Jocham, and J. M. Warnecke
Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer
Clin. Chem., December 1, 2007; 53(12): 2070 - 2077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Jiang, J. Pecha, I. Hoshino, D. Ankrapp, and H. Xiao
TIP30 Mutant Derived from Hepatocellular Carcinoma Specimens Promotes Growth of HepG2 Cells through Up-Regulation of N-cadherin
Cancer Res., April 15, 2007; 67(8): 3574 - 3582.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. L. Fridman, L. Tang, O. I. Kulaeva, B. Ye, Q. Li, F. Nahhas, P. C. Roberts, S. J. Land, J. Abrams, and M. A. Tainsky
Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 879 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. El Omari, L. E. Bird, C. E. Nichols, J. Ren, and D. K. Stammers
Crystal Structure of CC3 (TIP30): IMPLICATIONS FOR ITS ROLE AS A TUMOR SUPPRESSOR
J. Biol. Chem., May 6, 2005; 280(18): 18229 - 18236.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. W. King and E. Shtivelman
Inhibition of Nuclear Import by the Proapoptotic Protein CC3
Mol. Cell. Biol., August 15, 2004; 24(16): 7091 - 7101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Jiang, M. Ito, V. Piening, K. Bruck, R. G. Roeder, and H. Xiao
TIP30 Interacts with an Estrogen Receptor {alpha}-interacting Coactivator CIA and Regulates c-myc Transcription
J. Biol. Chem., June 25, 2004; 279(26): 27781 - 27789.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.